Gossamer Bio Inc (GOSS) stock news · rev $48.5M
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
This GOSS news page leads with what Gossamer Bio Inc filed — not a scraped headline mill.
No cached 8-K sentence for GOSS yet. We will not pad this page with generic market recap.
Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the GOSS stock page; for the tape open the quote page.
GOSS stock news FAQ
What are GOSS's latest revenue and net income?
Latest cached Gossamer Bio Inc (GOSS) revenue for Dec 31, 2025 was $48.5M. Net income was -$170.4M. Statements: https://lician.com/financials/goss
How did GOSS revenue change from the prior cached period?
Cached Gossamer Bio Inc (GOSS) revenue was down 57.7% from $114.7M (Dec 31, 2024) to $48.5M (Dec 31, 2025). Statements: https://lician.com/financials/goss
What is GOSS's market cap?
Gossamer Bio Inc (GOSS) market cap is $47.0M on the latest cached fundamentals snapshot.
What kind of company is GOSS?
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Where is GOSS stock news listed?
Cached stock news for Gossamer Bio Inc (GOSS) is listed at https://lician.com/news/goss. Filings: https://lician.com/sec/goss
Not investment advice.